The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects

NCT03634436 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesteremia

Interventions

DRUG: SHR-1209
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.